Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Oragenics Inc.

    AMEX: OGEN · Real-Time Price · USD
    4.40
    0.05 (1.15%)
    At close: Jun 17, 2025, 3:59 PM
    4.39
    -0.23%
    Pre-market: Jun 18, 2025, 07:15 AM EDT

    Oragenics Statistics

    Share Statistics

    Oragenics has 715.84K shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 715.84K

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0.03%

    Owned by Institutions (%)

    n/a
    		 1.87%

    Shares Floating

    n/a
    		 673.45K

    Failed to Deliver (FTD) Shares

    n/a
    		 62

    FTD / Avg. Volume

    n/a
    		 0.03%

    Short Selling Information

    The latest short interest is 2.42M, so 338.32% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 2.42M

    Short % of Shares Out

    n/a
    		 338.32%

    Short % of Float

    n/a
    		 346.76%

    Short Ratio (days to cover)

    n/a
    		 3.31

    Valuation Ratios

    The PE ratio is -0.23 and the forward PE ratio is -0.42. Oragenics's PEG ratio is 0.

    PE Ratio

    n/a
    		 -0.23

    Forward PE

    n/a
    		 -0.42

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.1

    PB Ratio

    n/a
    		 -11.54

    P/FCF Ratio

    n/a
    		 -0.28

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Oragenics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 0.87, with a Debt / Equity ratio of -1.55.

    Current Ratio

    n/a
    		 0.87

    Quick Ratio

    n/a
    		 0.87

    Debt / Equity

    n/a
    		 -1.55

    Debt / EBITDA

    n/a
    		 -0.03

    Debt / FCF

    n/a
    		 -0.04

    Interest Coverage

    n/a
    		 -353.99

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-3,522,666.67

    Employee Count

    n/a
    		 3

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by 187.58% in the last 52 weeks. The beta is 0.93, so Oragenics's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.93

    52-Week Price Change

    n/a
    		 187.58%

    50-Day Moving Average

    n/a
    		 3.16

    200-Day Moving Average

    n/a
    		 1.05

    Relative Strength Index (RSI)

    n/a
    		 51.68

    Average Volume (20 Days)

    n/a
    		 206,167

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -10.56M

    Net Income

    n/a
    		 -10.57M

    EBITDA

    n/a
    		 -10.56M

    EBIT

    n/a
    		 -10.6M

    Earnings Per Share (EPS)

    n/a
    		 -1.6
    Full Income Statement

    Balance Sheet

    The company has 864.84K in cash and 328.53K in debt, giving a net cash position of 536.31K.

    Cash & Cash Equivalents

    n/a
    		 864.84K

    Total Debt

    n/a
    		 328.53K

    Net Cash

    n/a
    		 536.31K

    Retained Earnings

    n/a
    		 -216.79M

    Total Assets

    n/a
    		 3.87M

    Working Capital

    n/a
    		 1.31M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -8.6M and capital expenditures 0, giving a free cash flow of -8.6M.

    Operating Cash Flow

    n/a
    		 -8.6M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -8.6M

    FCF Per Share

    n/a
    		 -1.3
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    OGEN does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for OGEN.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jun 3, 2025. It was a backward split with a ratio of 1:30.

    Last Split Date

    n/a
    		 Jun 3, 2025

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:30

    Scores

    Altman Z-Score

    n/a
    		 -87.01

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist